These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 19428841)

  • 1. Comparative analysis of the complete nucleotide sequences of measles, mumps, and rubella strain genomes contained in Priorix-Tetra and ProQuad live attenuated combined vaccines.
    Tillieux SL; Halsey WS; Sathe GM; Vassilev V
    Vaccine; 2009 Apr; 27(16):2265-73. PubMed ID: 19428841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A combination measles, mumps, rubella, and varicella vaccine (ProQuad) given to 4- to 6-year-old healthy children vaccinated previously with M-M-RII and Varivax.
    Reisinger KS; Brown ML; Xu J; Sullivan BJ; Marshall GS; Nauert B; Matson DO; Silas PE; Schödel F; Gress JO; Kuter BJ;
    Pediatrics; 2006 Feb; 117(2):265-72. PubMed ID: 16452343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of simultaneous administration of live measles vaccine on the "take rate" of live mumps vaccine.
    André FE; Peetermans J
    Dev Biol Stand; 1986; 65():101-7. PubMed ID: 3556770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and safety of two tetravalent (measles, mumps, rubella, varicella) vaccines coadministered with hepatitis a and pneumococcal conjugate vaccines to children twelve to fourteen months of age.
    Blatter MM; Klein NP; Shepard JS; Leonardi M; Shapiro S; Schear M; Mufson MA; Martin JM; Varman M; Grogg S; London A; Cambron P; Douha M; Nicholson O; da Costa C; Innis BL
    Pediatr Infect Dis J; 2012 Aug; 31(8):e133-40. PubMed ID: 22622699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measles, mumps, rubella vaccine (Priorix; GSK-MMR): a review of its use in the prevention of measles, mumps and rubella.
    Wellington K; Goa KL
    Drugs; 2003; 63(19):2107-26. PubMed ID: 12962524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
    Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study and evaluation of further attenuated, live measles vaccines alone and in combination with mumps and rubella vaccines.
    Wegmann A; Glück R; Just M; Mischler R; Paroz P; Germanier R
    Dev Biol Stand; 1986; 65():69-74. PubMed ID: 3556778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of reactogenicity and immunogenicity of new and established measles, mumps and rubella vaccines in healthy children.
    Usonis V; Bakasenas V; Chitour K; Clemens R
    Infection; 1998; 26(4):222-6. PubMed ID: 9717679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactogenicity and immunogenicity of a new measles-mumps-rubella vaccine containing RIT 4385 mumps virus strain in healthy Turkish children.
    Kanra G; Ceyhan M; Ozmert E
    Turk J Pediatr; 2000; 42(4):275-7. PubMed ID: 11196741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Priorix Tetra: a new combined vaccine against measles, rubella, mumps and varicella].
    Gabutti G; Azzari C
    Minerva Pediatr; 2008 Aug; 60(4):429-41. PubMed ID: 18511895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potency estimation of measles, mumps and rubella trivalent vaccines with quantitative PCR infectivity assay.
    Schalk JA; de Vries CG; Jongen PM
    Biologicals; 2005 Jun; 33(2):71-9. PubMed ID: 15939284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the safety and immunogenicity of a refrigerator-stable versus a frozen formulation of ProQuad (measles, mumps, rubella, and varicella virus vaccine live).
    Bernstein HH; Eves K; Campbell K; Black SB; Twiggs JD; Reisinger KS; Conti RM; Flodmark CE; Rombo L; Klopfer S; Schödel F; Hartzel J; Kuter BJ;
    Pediatrics; 2007 Jun; 119(6):e1299-305. PubMed ID: 17502347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rubini, a new live attenuated mumps vaccine virus strain for human diploid cells.
    Glück R; Hoskins JM; Wegmann A; Just M; Germanier R
    Dev Biol Stand; 1986; 65():29-35. PubMed ID: 3556774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measles, Mumps, Rubella Vaccine (PRIORIX): Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.
    Krow-Lucal E; Marin M; Shepersky L; Bahta L; Loehr J; Dooling K
    MMWR Morb Mortal Wkly Rep; 2022 Nov; 71(46):1465-1470. PubMed ID: 36395065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of rubella, mumps, and measles virus genomic RNA in cells from synovial fluid and peripheral blood in early rheumatoid arthritis.
    Zhang D; Nikkari S; Vainionpää R; Luukkainen R; Yli-Kerttula U; Toivanen P
    J Rheumatol; 1997 Jul; 24(7):1260-5. PubMed ID: 9228121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003.
    Asatryan A; Pool V; Chen RT; Kohl KS; Davis RL; Iskander JK;
    Vaccine; 2008 Feb; 26(9):1166-72. PubMed ID: 18255204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of early vaccination with two doses of tetravalent measles-mumps-rubella-varicella (MMRV) vaccine in healthy children from 9 months of age.
    Goh P; Lim FS; Han HH; Willems P
    Infection; 2007 Oct; 35(5):326-33. PubMed ID: 17710370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine.
    Ovsyannikova IG; Pankratz VS; Vierkant RA; Jacobson RM; Poland GA
    J Infect Dis; 2006 Mar; 193(5):655-63. PubMed ID: 16453260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elucidation of the full genetic information of Japanese rubella vaccines and the genetic changes associated with in vitro and in vivo vaccine virus phenotypes.
    Otsuki N; Abo H; Kubota T; Mori Y; Umino Y; Okamoto K; Takeda M; Komase K
    Vaccine; 2011 Feb; 29(10):1863-73. PubMed ID: 21251900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risks of convulsion and aseptic meningitis following measles-mumps-rubella vaccination in the United Kingdom.
    Miller E; Andrews N; Stowe J; Grant A; Waight P; Taylor B
    Am J Epidemiol; 2007 Mar; 165(6):704-9. PubMed ID: 17204517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.